In vitro effects of ciprofloxacin and roxithromycin on apoptosis of Jurkat T lymphocytes

Antimicrobial Agents and Chemotherapy

Volumn 47, Issue 3, 2003, Pages 1161-1164

  Jun, Yong Taek ^a   Kim, Hee Jung ^a   Song, Min Jin ^a   Lim, Ji Hyang ^a   Lee, Dong Gun ^a   Han, Kyung Ja ^a   Choi, Su Mi ^a   Yoo, Jin Hong ^a   Shin, Wan Shik ^a   Choi, Jung Hyun ^a,b  

^a The Catholic University of Korea   (South Korea)

^b The Catholic University of Korea   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE 3; CASPASE 8; CIPROFLOXACIN; FAS LIGAND; MACROLIDE; QUINOLINE DERIVED ANTIINFECTIVE AGENT; ROXITHROMYCIN;

APOPTOSIS; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG EFFECT; ENZYME ACTIVATION; ENZYME ACTIVITY; HUMAN; HUMAN CELL; LEUKEMIA CELL LINE; PRIORITY JOURNAL; PROTEIN EXPRESSION; T LYMPHOCYTE;

ANTI-BACTERIAL AGENTS; ANTI-INFECTIVE AGENTS; ANTIGENS, CD95; APOPTOSIS; BCL-2-ASSOCIATED X PROTEIN; CASPASES; CELL SURVIVAL; CIPROFLOXACIN; DNA FRAGMENTATION; ENZYME-LINKED IMMUNOSORBENT ASSAY; FAS LIGAND PROTEIN; FLUORESCEIN-5-ISOTHIOCYANATE; FLUORESCENT ANTIBODY TECHNIQUE; GENES, BCL-2; HUMANS; JURKAT CELLS; MEMBRANE GLYCOPROTEINS; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-BCL-2; ROXITHROMYCIN; T-LYMPHOCYTES;

EID: 0037417033     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.47.3.1161-1164.2003     Document Type: Article

References (34)

1. Andreoli, T. E. 1999. The apoptosis syndrome. Am. J. Med. 107:488-506.
2. Aoshiba, K., A. Nagai, and K. Konno. 1995. Erythromycin shortens neutrophil survival by accelerating apoptosis. Antimicrob. Agents Chemother. 39: 872-877.
3. Brunner, T., R. J. Mogil, D. LaFace, N. J. Yoo, A. Mahboubi, and F. Echeverri. 1995. Cell-autonomous Fas(CD95)/Fas-ligand interaction mediates activation-induced apoptosis in T-cell hybridomas. Nature 373:441-444.
4. Dearstyne, E. A., and N. I. Kervliet. 2002. Mechanism of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD)-induced decrease in anti-CD3-activated CD4+ T cells: the role of apoptosis, Fas, and TNF. Toxicology 170:139-151.
5. Dhein, J., H. Walczak, C. Bäumler, K. M. Debatin, and P. H. Krammer. 1995. Autocrine T-cell suicide mediated by APO-1(Fas/CD95). Nature 373: 438-441.
6. Herold, C., M. Ocker, M. Ganslmayer, H. Gerauer, E. G. Hahn, and D. Schuppan. 2002. Ciprofloxacin induces apoptosis and inhibits proliferation of human colorectal carcinoma cells. Br. J. Cancer 86: 443-448.
7. Itoh, N., Y. Tsujimoto, and S. Nagata. 1993. Effect of bcl-2 on Fas-mediated cell death. J. Immunol. 151:621-627.
8. Iwai, K., T. Miyawaki, T. Takizawa, A. Konno, K. Ohta, A. Yachie, H. Seki, and N. Taniguchi. 1994. Differential expression of bcl-2 and susceptibility to anti-Fas-mediated cell death in peripheral blood lymphocytes, monocytes, and neutrophils. Blood 84:1201-1208.
9. Janeway, C. A., P. Travers, M. Walport, and J. D. Capra (ed.). 1999. Immunobiology, 4th ed. Elsevier Science Ltd./Garland Publishing, New York, N.Y.
10. Ju, S. T., D. J. Panka, H. Cui, R. Ettinger, M. El-Khatib, D. H. Sherr, D. H., B. Z. Stanger, and A. Marshak-Rothstein. 1995. Fas(CD95)/FasL interaction required for programmed cell death after T-cell activation. Nature 373:444-448.
11. Juo, P., C. J. Kuno, J. Yuan, and J. Blenis. 1998. Essential requirement for caspase-8/FLICE in the initiation of the Fas-induced apoptotic cascade. Curr. Biol. 8:1001-1008.
12. Kawasaki, S., H. Takizawa, T. Ohtoshi, N. Takeuchi, T. Kohyama, H. Nakamura, T. Kasama, K. Kobayashi, K. Nakahara, Y. Morita, and K. Yamamoto. 1998. Roxithromycin inhibits cytokine production by and neutrophil attachment to human bronchial epithelial cells in vitro. Antimicrob. Agents Chemother. 42:1499-1502.
13. Khan, A., T. R. Slifer, and J. S. Remington. 1998. Effect of trovafloxacin on production of cytokines by human monocytes. Antimicrob. Agents Chemother. 42:1713-1717.
14. Koch, C. C., D. J. Esteban, A. C. Chin, M. E. Olson, R. R. Read, H. Ceri, D. W. Morck, and A. G. Buret. 2000. Apoptosis, oxidative metabolism and interleukin-8 production in human neutrophils exposed to azithromycin: effects of Streptococcus pneumoniae. J. Antimicrob. Chemother. 46:19-26.
15. Labro, M. T. 1997. The prohost effect of antimicrobial agents as a predictor of clinical outcome. J. Chemother. 9(Suppl. 1):100-108.
16. Labro, M. T. 1998. Immunologic effects of macrolides. Curr. Opin. Infect. Dis. 11:681-688.
17. Labro, M. T. 1998. Antibacterial agents-phagocytes: new concepts for old in immunomodulation. Int. J. Antimicrob. Agents 10:11-21.
18. Labro, M. T. 2000. Interference of antibacterial agents with phagocyte functions: immunomodulation or "immuno-fairy tales"? Clin. Microbiol. Rev. 13:615-650.
19. Liles, W. C., P. A. Kienner, J. A. Ledbetter, A. Aruffo, and S. J. Klebanoff. 1996. Differential expression of Fas (CD95) and Fas ligand on normal human phagocytes: implications for the regulation of apoptosis in neutrophils. J. Exp. Med. 184:429-440.
20. Liu, J., C. A. Kuszynski, and B. T. Baxter. 1999. Doxycycline induced Fas/Fas ligand-mediated apoptosis in Jurkat T lymphocytes. Biochem. Biophys. Res. Commun. 260:562-567.
21. Morikawa, K., F. Oseko, S. Morikawa, and K. Iwamoto. 1994. Immunomodulatory effects of three macrolides, midecamycin acetate, josamycin, and clarithromycin, on human T-lymphocyte function in vitro. Antimicrob. Agents Chemother. 38:2643-2647.
22. Morikawa, K., H. Watabe, M. Araake, and S. Morikawa. 1996. Modulatory effect of antibiotics on cytokine production by human monocytes in vitro. Antimicrob. Agents Chemother. 40:1366-1370.
23. Murphy, K., S. B. Haudek, M. Thompson, and B. P. Giroir. 1998. Molecular biology of septic shock. New Horiz. 6:181A-193A.
24. Ono, Y., Y. Ohmoto, K. Ono, Y. Sakada, and K. Murata. 2000. Effect of grepafloxacin on cytokine production in vivo. J. Antimicrob. Chemother. 46:91-94.
25. Purswani, M., S. Eckert, H. Arora, R. Johann-Liang, and G. J. Noel. 2000. The effect of three broad-spectrum antimicrobials on mononuclear cell responses to encapsulated bacteria: evidence for down-regulation of cytokine mRNA transcription by trovafloxacin. J. Antimicrob. Chemother. 46:921-929.
26. Raff, M. 1998. Cell suicide for beginners. Nature 396:119-122.
27. Riesbeck, K., and A. Forsgren. 1994. Limited effects of temifloxacin compared with ciprofloxacin on T-lymphocyte function. Antimicrob. Agents Chemother. 38:879-882.
28. Sassa, K., Y. Muzushima, and M. Kobayashi. 1999. Differential modulatory effects of clarithromycin on the production of cytokines by a tumor. Antimicrob. Agents Chemother. 43:2787-2789.
29. Schultz, M. J., P. Speelman, S. Zaat, S. J. J. van Deventer, and T. van der Poll. 1998. Erythromycin inhibits tumor necrosis factor alpha and interleukin 6 production induced by heat-killed Streptococcus pneumoniae in whole blood. Antimicrob. Agents Chemother. 42:1605-1609.
30. Singh, A., and B. B. Aggarwal. 1998. Death domain receptors and their role in cell demise. J. Interferon Cytokine Res. 18:439-450.
31. Sun, X. M., M. MacFarlane, J. Zhuang, B. B. Wolf, D. R. Green, and G. M. Cohen. 1999. Distinct caspase cascades are initiated in receptor-mediated and chemical-induced apoptosis. J. Biol. Chem. 274:5053-5060.
32. Thompson, C. B. 1995. Apoptosis in the pathogenesis and treatment of disease. Science 267:1456-1462.
33. Vazifeh, D., A. Bryskier, and M. T. Labro. 2000. Effect of proinflammatory cytokines on the interplay between roxithromycin, HMR 3647, or HMR 3004 and human polymorphonuclear neutrophils. Antimicrob. Agents Chemother. 44:511-521.
34. Woodle, E. S., and H. R. Kulkarni. 1998. Programmed cell death. Transplantation 65:681-691.